-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DxvBovTEnqqr+MwAtIfFvVu5dkJJURpoYIU7gDKXqcrBbuGmgD6wXX3sNVIoRu+I lWBD/htuH4KrSs72G5sxqA== 0001033409-07-000029.txt : 20070717 0001033409-07-000029.hdr.sgml : 20070717 20070717144727 ACCESSION NUMBER: 0001033409-07-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070716 FILED AS OF DATE: 20070717 DATE AS OF CHANGE: 20070717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 07983931 BUSINESS ADDRESS: BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-07-16 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001033409 ESHELMAN FREDRIC N 6814 TOWLES ROAD WILMINGTON NC 28409 1 1 0 0 CEO Common Stock 2007-07-16 4 S 0 500 38.37 D 8417026 D Common Stock 2007-07-16 4 S 0 400 38.38 D 8416626 D Common Stock 2007-07-16 4 S 0 800 38.39 D 8415826 D Common Stock 2007-07-16 4 S 0 400 38.40 D 8415426 D Common Stock 2007-07-16 4 S 0 500 38.41 D 8414926 D Common Stock 2007-07-16 4 S 0 200 38.42 D 8414726 D Common Stock 2007-07-16 4 S 0 300 38.43 D 8414426 D Common Stock 2007-07-16 4 S 0 300 38.44 D 8414126 D Common Stock 2007-07-16 4 S 0 539 38.45 D 8413587 D Common Stock 2007-07-16 4 S 0 1161 38.46 D 8412426 D Common Stock 2007-07-16 4 S 0 1000 38.47 D 8411426 D Common Stock 2007-07-16 4 S 0 1500 38.48 D 8409926 D Common Stock 2007-07-16 4 S 0 1000 38.49 D 8408926 D Common Stock 2007-07-16 4 S 0 400 38.50 D 8408526 D Common Stock 2007-07-16 4 S 0 300 38.51 D 8408226 D Common Stock 2007-07-16 4 S 0 1300 38.52 D 8406926 D Common Stock 2007-07-16 4 S 0 370 38.53 D 8406556 D Common Stock 2007-07-16 4 S 0 900 38.54 D 8405656 D Common Stock 2007-07-16 4 S 0 530 38.55 D 8405126 D Common Stock 2007-07-16 4 S 0 1300 38.56 D 8403826 D Common Stock 2007-07-16 4 S 0 800 38.57 D 8403026 D Common Stock 2007-07-16 4 S 0 100 38.58 D 8402926 D Common Stock 2007-07-16 4 S 0 700 38.60 D 8402226 D Common Stock 2007-07-16 4 S 0 300 38.61 D 8401926 D Common Stock 2007-07-16 4 S 0 100 38.62 D 8401826 D Common Stock 2007-07-16 4 S 0 300 38.64 D 8401526 D Common Stock 2007-07-16 4 S 0 2700 38.65 D 8398826 D Common Stock 2007-07-16 4 S 0 1100 38.66 D 8397726 D Common Stock 2007-07-16 4 S 0 1100 38.67 D 8396626 D Common Stock 2007-07-16 4 S 0 500 38.68 D 8396126 D This Form 4 is 2 of 4 Forms 4 being filed to report the sale of stock on July 16, 2007 pursuant to the 10b5-1 trading plan adopted by the Reporting Person. Lisa C. Noecker attorney-in-fact for Fred N. Eshelman 2007-07-17 -----END PRIVACY-ENHANCED MESSAGE-----